TY - JOUR
T1 - An evolutionary NS1 mutation enhances Zika virus evasion of host interferon induction
AU - Xia, Hongjie
AU - Luo, Huanle
AU - Shan, Chao
AU - Muruato, Antonio E.
AU - Nunes, Bruno T.D.
AU - Medeiros, Daniele B.A.
AU - Zou, Jing
AU - Xie, Xuping
AU - Giraldo, Maria Isabel
AU - Vasconcelos, Pedro F.C.
AU - Weaver, Scott C.
AU - Wang, Tian
AU - Rajsbaum, Ricardo
AU - Shi, Pei Yong
N1 - Publisher Copyright:
© The Author(s) 2018.
PY - 2018/12/1
Y1 - 2018/12/1
N2 - Virus-host interactions determine an infection outcome. The Asian lineage of Zika virus (ZIKV), responsible for the recent epidemics, has fixed a mutation in the NS1 gene after 2012 that enhances mosquito infection. Here we report that the same mutation confers NS1 to inhibit interferon-β induction. This mutation enables NS1 binding to TBK1 and reduces TBK1 phosphorylation. Engineering the mutation into a pre-epidemic ZIKV strain debilitates the virus for interferon-β induction; reversing the mutation in an epidemic ZIKV strain invigorates the virus for interferon-β induction; these mutational effects are lost in IRF3-knockout cells. Additionally, ZIKV NS2A, NS2B, NS4A, NS4B, and NS5 can also suppress interferon-β production through targeting distinct components of the RIG-I pathway; however, for these proteins, no antagonistic difference is observed among various ZIKV strains. Our results support the mechanism that ZIKV has accumulated mutation(s) that increases the ability to evade immune response and potentiates infection and epidemics.
AB - Virus-host interactions determine an infection outcome. The Asian lineage of Zika virus (ZIKV), responsible for the recent epidemics, has fixed a mutation in the NS1 gene after 2012 that enhances mosquito infection. Here we report that the same mutation confers NS1 to inhibit interferon-β induction. This mutation enables NS1 binding to TBK1 and reduces TBK1 phosphorylation. Engineering the mutation into a pre-epidemic ZIKV strain debilitates the virus for interferon-β induction; reversing the mutation in an epidemic ZIKV strain invigorates the virus for interferon-β induction; these mutational effects are lost in IRF3-knockout cells. Additionally, ZIKV NS2A, NS2B, NS4A, NS4B, and NS5 can also suppress interferon-β production through targeting distinct components of the RIG-I pathway; however, for these proteins, no antagonistic difference is observed among various ZIKV strains. Our results support the mechanism that ZIKV has accumulated mutation(s) that increases the ability to evade immune response and potentiates infection and epidemics.
UR - http://www.scopus.com/inward/record.url?scp=85041327442&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85041327442&partnerID=8YFLogxK
U2 - 10.1038/s41467-017-02816-2
DO - 10.1038/s41467-017-02816-2
M3 - Article
C2 - 29379028
AN - SCOPUS:85041327442
SN - 2041-1723
VL - 9
JO - Nature communications
JF - Nature communications
IS - 1
M1 - 414
ER -